| scholarly article | Q13442814 |
| P50 | author | Emily N C Manoogian | Q87465909 |
| P2093 | author name string | Satchidananda Panda | |
| Pam R Taub | |||
| Gabriele Sulli | |||
| P2860 | cites work | Bmal1 function in skeletal muscle regulates sleep. | Q41546143 |
| Circadian Rhythm Disruption Promotes Lung Tumorigenesis | Q41921459 | ||
| Cryptochromerestores dampened circadian rhythms and promotes healthspan in agingDrosophila | Q41946748 | ||
| High incidence of T-cell lymphomas in mice deficient in the retinoid-related orphan receptor RORgamma. | Q43878486 | ||
| Sleep disorders and inflammatory disease activity: chicken or the egg? | Q45002254 | ||
| Circadian clock cryptochrome proteins regulate autoimmunity | Q46273899 | ||
| Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial | Q46799709 | ||
| Time-Restricted Feeding Improves Circadian Dysfunction as well as Motor Symptoms in the Q175 Mouse Model of Huntington’s Disease | Q47095856 | ||
| Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis | Q47110918 | ||
| Time-Restricted Feeding Alters the Innate Immune Response to Bacterial Endotoxin | Q47332673 | ||
| Night Shift Work Increases the Risks of Multiple Primary Cancers in Women: A Systematic Review and Meta-analysis of 61 Articles | Q47556670 | ||
| Disruption of Bmal1 Impairs Blood-Brain Barrier Integrity via Pericyte Dysfunction. | Q47799570 | ||
| Effect of running wheel availability on circadian patterns of sleep and wakefulness in mice | Q48963641 | ||
| Diurnal transcriptome atlas of a primate across major neural and peripheral tissues | Q50036475 | ||
| Increased cell death and delayed development in the cerebellum of mice lacking the rev-erbA(alpha) orphan receptor. | Q52170388 | ||
| A Circadian Clock in the Blood-Brain Barrier Regulates Xenobiotic Efflux. | Q52662085 | ||
| Molecular Cogs: Interplay between Circadian Clock and Cell Cycle. | Q52689383 | ||
| Circadian behavior is light-reprogrammed by plastic DNA methylation. | Q52879320 | ||
| Discovery of 2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide derivatives as new RORγ inhibitors using virtual screening, synthesis and biological evaluation | Q53287859 | ||
| Identification of an aminothiazole series of RORβ modulators. | Q64937732 | ||
| Circadian timing of cancer chemotherapy | Q69884877 | ||
| Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy | Q73685231 | ||
| Increasing Human Th17 Differentiation through Activation of Orphan Nuclear Receptor Retinoid Acid-Related Orphan Receptor γ (RORγ) by a Class of Aryl Amide Compounds | Q84382619 | ||
| Cryptochromes mediate rhythmic repression of the glucocorticoid receptor | Q24299891 | ||
| Obesity and metabolic syndrome in circadian Clock mutant mice | Q24627935 | ||
| Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists | Q24629345 | ||
| Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes | Q24633002 | ||
| The emerging roles of melanopsin in behavioral adaptation to light | Q24633234 | ||
| Variants in MTNR1B influence fasting glucose levels | Q24642630 | ||
| Circadian timekeeping and output mechanisms in animals | Q26823056 | ||
| Genetic basis of human circadian rhythm disorders | Q26865668 | ||
| Circadian control of the immune system | Q27023060 | ||
| MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective | Q28083929 | ||
| The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo | Q28206180 | ||
| Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor | Q28211084 | ||
| Melanopsin (Opn4) requirement for normal light-induced circadian phase shifting | Q28217410 | ||
| Haematopoietic stem cell release is regulated by circadian oscillations | Q28267721 | ||
| Circadian clock mutation disrupts estrous cyclicity and maintenance of pregnancy | Q28275816 | ||
| An action spectrum for melatonin suppression: evidence for a novel non-rod, non-cone photoreceptor system in humans | Q28346116 | ||
| Impact of circadian misalignment on energy metabolism during simulated nightshift work | Q28383884 | ||
| Shift Work and Circadian Dysregulation of Reproduction | Q28387009 | ||
| Circadian System and Glucose Metabolism: Implications for Physiology and Disease | Q28392828 | ||
| Clock genes, pancreatic function, and diabetes | Q28393998 | ||
| Disruption of the Circadian Clock in Mice Increases Intestinal Permeability and Promotes Alcohol-Induced Hepatic Pathology and Inflammation | Q28534128 | ||
| Rotating night shift work and risk of type 2 diabetes: two prospective cohort studies in women | Q28741820 | ||
| Entrainment of the circadian clock in the liver by feeding | Q29615668 | ||
| A functional genomics strategy reveals Rora as a component of the mammalian circadian clock | Q29616297 | ||
| Early aging and age-related pathologies in mice deficient in BMAL1, the core componentof the circadian clock | Q29616363 | ||
| The genetics of mammalian circadian order and disorder: implications for physiology and disease | Q29616366 | ||
| Central and peripheral circadian clocks in mammals | Q29616556 | ||
| Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus | Q29619114 | ||
| Measuring and using light in the melanopsin age. | Q30361752 | ||
| Dysregulation of inflammatory responses by chronic circadian disruption | Q30429758 | ||
| The role of circadian clock genes in mental disorders | Q35454549 | ||
| The nuclear receptor REV-ERBα mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokines. | Q35673857 | ||
| Identification of SR2211: a potent synthetic RORγ-selective modulator. | Q35903192 | ||
| Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokines | Q36140475 | ||
| Minireview: timely ovulation: circadian regulation of the female hypothalamo-pituitary-gonadal axis | Q36350872 | ||
| Health consequences of electric lighting practices in the modern world: a report on the National Toxicology Program's workshop on shift work at night, artificial light at night, and circadian disruption | Q36887762 | ||
| ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer | Q37270422 | ||
| Circadian clock proteins regulate neuronal redox homeostasis and neurodegeneration. | Q37383982 | ||
| Pharmacologic modulation of RORγt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis | Q37460263 | ||
| Time of feeding and the intrinsic circadian clock drive rhythms in hepatic gene expression | Q37482097 | ||
| Shift work and cardiovascular disease - pathways from circadian stress to morbidity. | Q37678222 | ||
| Gastrointestinal disorders among shift workers. | Q37681334 | ||
| Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease | Q37772758 | ||
| Circadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications. | Q37798715 | ||
| Circadian rhythms and depression: human psychopathology and animal models. | Q37922874 | ||
| Chronic insomnia | Q37977721 | ||
| Shift work and cancer risk: Potential mechanistic roles of circadian disruption, light at night, and sleep deprivation | Q38058576 | ||
| The therapeutic potential of nuclear receptor modulators for treatment of metabolic disorders: PPARγ, RORs, and Rev-erbs | Q38179699 | ||
| Late dinner impairs glucose tolerance in MTNR1B risk allele carriers: A randomized, cross-over study. | Q38377376 | ||
| Identification of a selective RORγ ligand that suppresses T(H)17 cells and stimulates T regulatory cells | Q38458000 | ||
| Coupling between the Circadian Clock and Cell Cycle Oscillators: Implication for Healthy Cells and Malignant Growth | Q38510094 | ||
| Dosing-Time Makes the Poison: Circadian Regulation and Pharmacotherapy | Q38804914 | ||
| Immunity around the clock | Q39019210 | ||
| Mechanisms linking circadian clocks, sleep, and neurodegeneration | Q39019213 | ||
| Does the Time of Radiotherapy Affect Treatment Outcomes? A Review of the Literature | Q39052238 | ||
| Circadian rhythms, time-restricted feeding, and healthy aging. | Q39054689 | ||
| Optimized chemical probes for REV-ERBα. | Q39154797 | ||
| Phosphorylation Is a Central Mechanism for Circadian Control of Metabolism and Physiology | Q39211113 | ||
| A common variant in MTNR1B, encoding melatonin receptor 1B, is associated with type 2 diabetes and fasting plasma glucose in Han Chinese individuals | Q39875191 | ||
| The Small Molecule Nobiletin Targets the Molecular Oscillator to Enhance Circadian Rhythms and Protect against Metabolic Syndrome. | Q40204797 | ||
| Self-regulation and household routines at age three and obesity at age eleven: longitudinal analysis of the UK Millennium Cohort Study | Q40230938 | ||
| Lymphocyte Circadian Clocks Control Lymph Node Trafficking and Adaptive Immune Responses | Q40372349 | ||
| Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunity | Q40806737 | ||
| Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice. | Q40851574 | ||
| The circadian clock regulates inflammatory arthritis. | Q41481270 | ||
| Aberrant light directly impairs mood and learning through melanopsin-expressing neurons | Q30532692 | ||
| Small-molecule antagonists of melanopsin-mediated phototransduction. | Q30557746 | ||
| A Smartphone App Reveals Erratic Diurnal Eating Patterns in Humans that Can Be Modulated for Health Benefits | Q33445269 | ||
| Systems Chronotherapeutics | Q33573675 | ||
| Disrupting circadian homeostasis of sympathetic signaling promotes tumor development in mice | Q33601559 | ||
| GSK4112, a Small Molecule Chemical Probe for the Cell Biology of the Nuclear Heme Receptor Rev-erbα | Q33647307 | ||
| CYCLOPS reveals human transcriptional rhythms in health and disease | Q33719425 | ||
| Small-molecule RORγt antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms | Q33791610 | ||
| Global rise of potential health hazards caused by blue light-induced circadian disruption in modern aging societies | Q33807734 | ||
| Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial | Q34153496 | ||
| Role of melanopsin in circadian responses to light | Q34164611 | ||
| Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-β | Q34264573 | ||
| Rev-erbα and Rev-erbβ coordinately protect the circadian clock and normal metabolic function | Q34265770 | ||
| Identification of SR1078, a synthetic agonist for the orphan nuclear receptors RORα and RORγ. | Q34414231 | ||
| Light as a central modulator of circadian rhythms, sleep and affect. | Q34424070 | ||
| A circadian gene expression atlas in mammals: implications for biology and medicine | Q34445166 | ||
| Time-restricted feeding is a preventative and therapeutic intervention against diverse nutritional challenges | Q34451866 | ||
| Effects of eight weeks of time-restricted feeding (16/8) on basal metabolism, maximal strength, body composition, inflammation, and cardiovascular risk factors in resistance-trained males | Q34542562 | ||
| CRY2 and FBXL3 Cooperatively Degrade c-MYC. | Q34544579 | ||
| Circadian physiology of metabolism | Q34545822 | ||
| Deficiency of circadian protein CLOCK reduces lifespan and increases age-related cataract development in mice | Q34554309 | ||
| Identification of SR8278, a synthetic antagonist of the nuclear heme receptor REV-ERB. | Q34587720 | ||
| Circadian chemotherapy for gynecological and genitourinary cancers | Q34606499 | ||
| High-fat diet disrupts behavioral and molecular circadian rhythms in mice | Q34710085 | ||
| An epithelial circadian clock controls pulmonary inflammation and glucocorticoid action | Q34718771 | ||
| Identification of SR3335 (ML-176): a synthetic RORα selective inverse agonist | Q34789625 | ||
| Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion | Q34897184 | ||
| A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk | Q34897205 | ||
| Ursolic acid suppresses interleukin-17 (IL-17) production by selectively antagonizing the function of RORgamma t protein | Q35067655 | ||
| In-vivo quantitative proteomics reveals a key contribution of post-transcriptional mechanisms to the circadian regulation of liver metabolism. | Q35082239 | ||
| Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand | Q35143424 | ||
| Photoentrainment and pupillary light reflex are mediated by distinct populations of ipRGCs | Q35148871 | ||
| Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity | Q35210669 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 812-827 | |
| P577 | publication date | 2018-07-27 | |
| P1433 | published in | Trends in Pharmacological Sciences | Q2451474 |
| P1476 | title | Training the Circadian Clock, Clocking the Drugs, and Drugging the Clock to Prevent, Manage, and Treat Chronic Diseases | |
| P478 | volume | 39 |
| Q92711846 | Chronotherapy of Non-Steroidal Anti-Inflammatory Drugs May Enhance Postoperative Recovery |
| Q58595056 | Circadian disruption: what do we actually mean? |
| Q92383546 | Circadian rhythms: a regulator of gastrointestinal health and dysfunction |
| Q90059243 | Controlling the Circadian Clock with High Temporal Resolution through Photodosing |
| Q92155159 | Fasting Physiology and Therapeutic Diets: A Look Back to the Future |
| Q90483971 | Insights About Circadian Clock and Molecular Pathogenesis in Gliomas |
| Q92675538 | Interplay between Circadian Clock and Cancer: New Frontiers for Cancer Treatment |
| Q61812343 | Small Molecule Modulators of the Circadian Molecular Clock With Implications for Neuropsychiatric Diseases |
| Q90167723 | Spatiotemporal gating of SIRT1 functions by O-GlcNAcylation is essential for liver metabolic switching and prevents hyperglycemia |
| Q92233885 | Systems approach reveals photosensitivity and PER2 level as determinants of clock-modulator efficacy |
| Q90746439 | Targeting REV-ERBα for therapeutic purposes: promises and challenges |
| Q92051267 | The Putatively Specific Synthetic REV-ERB Agonist SR9009 Inhibits IgE- and IL-33-Mediated Mast Cell Activation Independently of the Circadian Clock |
Search more.